EX-FILING FEES
Published on September 11, 2024
Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
LENZ Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
Security
Class
Title
|
Fee
Calculation
or Carry
Forward
Rule
|
Amount
Registered (1)
|
Proposed
Maximum
Offering
Price Per
Unit (2)
|
Maximum
Aggregate
Offering
Price
|
Fee
Rate
|
Amount of
Registration
Fee
|
Carry Forward Form Type | Carry Forward File Number |
Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | ||||||||||||||||||||||||
| Equity |
Common Stock,
$0.00001
par value
per share
|
457(c) |
1,578,947(2)
|
$24.08(3)
|
$38,021,043.76 |
$147.60 per $1,000,000 | $5,611.91 |
||||||||||||||||||||||||||||
| Total Offering Amounts | $38,021,043.76 |
$5,611.91 |
|||||||||||||||||||||||||||||||||
| Total Fees Previously Paid | — | ||||||||||||||||||||||||||||||||||
| Total Fee Offsets | — | ||||||||||||||||||||||||||||||||||
| Net Fee Due | $5,611.91 |
||||||||||||||||||||||||||||||||||
(1)Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the registrant’s common stock (“Common Stock”) that become issuable as a result of any stock dividend, stock split, recapitalization, or other similar transaction effected without the receipt of consideration that results in an increase to the number of outstanding shares of Common Stock, as applicable.
(2)The number of shares of Common Stock being registered hereunder are being registered for sale by the selling stockholder named in this Registration Statement, and represents 1,578,947 shares of Common Stock issued in the July 2024 PIPE Financing.
(3)Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $24.08, which is the average of the high and low prices of shares of Common Stock on The Nasdaq Global Select Market on September 6, 2024 (such date being within five business days of the date that this Registration Statement was filed with the U.S. Securities and Exchange Commission).